Income Statement (ASTRIA/THERAPEUTICS)

Technical Analysis Historical Data Financials News & Analysis

ASTRIA/THERAPEUTICS NEWS

Astria Therapeutics, Inc. (NASDAQ:ATXS) Receives Consensus Rating of “Buy” from Analysts By MarketBeat - 2 days ago

Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has earned a consensus rating of “Buy” from the seven ratings firms that are covering the firm, MarketBeat.com reports. Five equities researc… [+3728 chars]...

Read more
4,600 Shares in Astria Therapeutics, Inc. (NASDAQ:ATXS) Purchased by KLP Kapitalforvaltning AS By MarketBeat - 2 weeks ago

KLP Kapitalforvaltning AS purchased a new position in Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm purchased 4,600 shares of th… [+3947 chars]...

Read more
Brokerages Set Astria Therapeutics, Inc. (NASDAQ:ATXS) Target Price at $26.60 By MarketBeat - 4 weeks ago

Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has received an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. … [+4007 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		183.24 1.24
0.68%
CVX 		136.01 -3.29
-2.36%
CAT 		309.27 1.87
0.61%
INTC 		20.09 -0.25
-1.23%
MSFT 		391.96 -2.08
-0.53%
DIS 		90.89 -0.28
-0.31%
DOW 		30.59 -0.06
-0.2%
CSCO 		57.73 0.39
0.68%
GS 		547.55 -1.37
-0.25%